Copenhagen, Denmark

Elsesbet Ostergaard Nielsen

This inventor holds 1 USPTO granted patent. Top assignee: Neurosearch A/s. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elsesbet Ostergaard Nielsen. Retrieved from https://idiyas.com/inventor/elsesbet-ostergaard-nielsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elsesbet Ostergaard Nielsen: Innovator in AMPA Receptor Modulation

Introduction

Elisesbet Ostergaard Nielsen is a notable inventor based in Kobenhaven K, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that act as positive modulators of the AMPA receptor.

Latest Patents

Nielsen holds a patent for "Compounds and their use as positive AMPA receptor modulators." This invention provides novel compounds represented by a specific general formula. The compounds are designed to be useful as positive modulators of the AMPA receptor, which plays a crucial role in synaptic transmission and plasticity in the brain.

Career Highlights

Nielsen is associated with Neurosearch A/S, a company that focuses on the development of innovative treatments for neurological disorders. His work at Neurosearch has been instrumental in advancing research in this area.

Collaborations

Throughout his career, Nielsen has collaborated with esteemed colleagues, including Alex Haaht Gouliaev and Mogens Larsen. These partnerships have contributed to the success of his research and the development of new therapeutic compounds.

Conclusion

Elisesbet Ostergaard Nielsen is a prominent figure in the field of AMPA receptor modulation, with a patent that showcases his innovative approach to pharmacology. His work continues to influence the development of treatments for neurological conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…